Dr. Paul Sax discusses the decision to resume using the Johnson & Johnson vaccine in
HIV and ID Observations.
The “pause” on the one-shot Johnson & Johnson COVID-19 vaccine is over. In the latest HIV and ID Observations blog post, Dr. Paul Sax explains why this decision surprised him.
Do you want to be notified whenever Dr. Sax posts? Sign up to receive notifications by email by using the Subscribe box.
Want to see more from NEJM Journal Watch? Register here.